Process View
Any process that activates or increases the frequency, rate or extent of neuron death.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of neuron death"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| BCL2 | B-cell CLL/lymphoma 2 | 0.877 | Human | |
| CREBBP | CREB binding protein | 0.832 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.812 | Mouse Rat | |
| TP53 | tumor protein p53 | 0.693 | Zebrafish Mouse | |
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.655 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.618 | Mouse | |
| XIAP | X-linked inhibitor of apoptosis | 0.558 | ||
| BCL2L1 | BCL2-like 1 | 0.501 | Human | |
| BAD | BCL2-associated agonist of cell death | 0.486 | ||
| BAX | BCL2-associated X protein | 0.467 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.381 | ||
| MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 0.364 | ||
| AR | androgen receptor | 0.215 | ||
| JUN | jun proto-oncogene | 0.207 | Rat | |
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.196 | ||
| BID | BH3 interacting domain death agonist | 0.193 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.167 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.126 | Mouse | |
| LDLR | low density lipoprotein receptor | 0.119 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.104 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.101 | ||
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.089 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.086 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.083 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.072 | Mouse | |
| ATF3 | activating transcription factor 3 | 0.065 | ||
| MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.059 | ||
| APP | amyloid beta (A4) precursor protein | 0.054 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.052 | ||
| S100B | S100 calcium binding protein B | 0.050 | ||
| IER2 | immediate early response 2 | 0.049 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.047 | Rat | |
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.047 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.047 | Human | |
| HIPK2 | homeodomain interacting protein kinase 2 | 0.046 | ||
| MEF2A | myocyte enhancer factor 2A | 0.045 | ||
| CEBPG | CCAAT/enhancer binding protein (C/EBP), gamma | 0.045 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.044 | Rat | |
| BAIAP2 | BAI1-associated protein 2 | 0.038 | ||
| VAC14 | Vac14 homolog (S. cerevisiae) | 0.036 | ||
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.035 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.034 | ||
| SH3BP4 | SH3-domain binding protein 4 | 0.034 | ||
| PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.033 | Mouse | |
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.033 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.032 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.032 | ||
| HP | haptoglobin | 0.032 | ||
| ARRB1 | arrestin, beta 1 | 0.031 | ||
| A2M | alpha-2-macroglobulin | 0.030 | ||
| DAXX | death-domain associated protein | 0.030 | ||
| ZNF3 | zinc finger protein 3 | 0.029 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.028 | ||
| HUWE1 | HECT, UBA and WWE domain containing 1 | 0.027 | ||
| EP300 | E1A binding protein p300 | 0.027 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.026 | ||
| APOC1 | apolipoprotein C-I | 0.026 | ||
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.026 | ||
| DIABLO | diablo, IAP-binding mitochondrial protein | 0.026 | ||
| ENG | endoglin | 0.026 | ||
| MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.024 | ||
| ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.024 | ||
| CCDC6 | coiled-coil domain containing 6 | 0.024 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.023 | Mouse | |
| MAPK9 | mitogen-activated protein kinase 9 | 0.023 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.021 | ||
| ALK | anaplastic lymphoma receptor tyrosine kinase | 0.021 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.021 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.019 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.018 | ||
| SKA3 | spindle and kinetochore associated complex subunit 3 | 0.018 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.018 | ||
| TRIB3 | tribbles homolog 3 (Drosophila) | 0.017 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.017 | ||
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.016 | ||
| TP53BP1 | tumor protein p53 binding protein 1 | 0.016 | ||
| TCF4 | transcription factor 4 | 0.016 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.016 | ||
| CHERP | calcium homeostasis endoplasmic reticulum protein | 0.016 | ||
| SPECC1L | sperm antigen with calponin homology and coiled-coil domains 1-like | 0.016 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.016 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.015 | ||
| ATF2 | activating transcription factor 2 | 0.015 | ||
| LRDD | leucine-rich repeats and death domain containing | 0.015 | ||
| MUL1 | mitochondrial E3 ubiquitin protein ligase 1 | 0.015 | ||
| BECN1 | beclin 1, autophagy related | 0.015 | ||
| PAK4 | p21 protein (Cdc42/Rac)-activated kinase 4 | 0.015 | ||
| TTR | transthyretin | 0.015 | ||
| BBC3 | BCL2 binding component 3 | 0.014 | ||
| BTRC | beta-transducin repeat containing | 0.014 | ||
| MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 0.014 | ||
| BIRC2 | baculoviral IAP repeat containing 2 | 0.014 | ||
| PAK1 | p21 protein (Cdc42/Rac)-activated kinase 1 | 0.014 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.013 | ||
| TNF | tumor necrosis factor | 0.013 | ||
| MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.013 | ||
| PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.013 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.013 | ||
| KRT8 | keratin 8 | 0.013 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.013 | ||
| CCNE1 | cyclin E1 | 0.012 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.012 | ||
| ARRB2 | arrestin, beta 2 | 0.012 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.012 | ||
| FES | feline sarcoma oncogene | 0.012 | ||
| CABLES1 | Cdk5 and Abl enzyme substrate 1 | 0.012 | ||
| ESR1 | estrogen receptor 1 | 0.012 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.012 | ||
| CAV2 | caveolin 2 | 0.011 | ||
| ALB | albumin | 0.011 | ||
| C4orf14 | chromosome 4 open reading frame 14 | 0.011 | ||
| IDE | insulin-degrading enzyme | 0.011 | ||
| KCTD1 | potassium channel tetramerisation domain containing 1 | 0.011 | ||
| SKA1 | spindle and kinetochore associated complex subunit 1 | 0.011 | ||
| TRIP10 | thyroid hormone receptor interactor 10 | 0.011 | ||
| PAK7 | p21 protein (Cdc42/Rac)-activated kinase 7 | 0.010 | ||
| CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0.010 | ||
| DAB2IP | DAB2 interacting protein | 0.010 | ||
| FSTL1 | follistatin-like 1 | 0.010 | ||
| IRF3 | interferon regulatory factor 3 | 0.010 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.010 | ||
| ING1 | inhibitor of growth family, member 1 | 0.010 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.010 |